Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,337 | 17 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Inari Medical, Inc. | $361.30 | 2 | $0 (2023) |
| Melinta Therapeutics, Inc. | $197.81 | 2 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $156.54 | 2 | $0 (2017) |
| PORTOLA PHARMACEUTICALS, INC. | $149.59 | 2 | $0 (2019) |
| Valeant Pharmaceuticals North America LLC | $114.02 | 2 | $0 (2017) |
| The Medicines Company | $93.74 | 1 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $87.77 | 1 | $0 (2018) |
| Relypsa, Inc. | $63.25 | 1 | $0 (2017) |
| La Jolla Pharmaceutical Company | $43.13 | 1 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $34.13 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $177.25 | 1 | Inari Medical, Inc. ($177.25) |
| 2022 | $204.80 | 2 | Inari Medical, Inc. ($184.05) |
| 2020 | $34.13 | 1 | Janssen Pharmaceuticals, Inc ($34.13) |
| 2019 | $297.90 | 4 | PORTOLA PHARMACEUTICALS, INC. ($149.59) |
| 2018 | $195.30 | 3 | Melinta Therapeutics, Inc. ($92.63) |
| 2017 | $427.55 | 6 | E.R. Squibb & Sons, L.L.C. ($156.54) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2023 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $177.25 | General |
| Category: VTE | ||||||
| 11/22/2022 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $184.05 | General |
| Category: VTE | ||||||
| 09/13/2022 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA, ZINPLAVA | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/28/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $34.13 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/30/2019 | PORTOLA PHARMACEUTICALS, INC. | ANDEXXA (Biological) | Food and Beverage | Cash or cash equivalent | $18.78 | General |
| Category: HEMATOLOGY/NEUROLOGY | ||||||
| 05/09/2019 | Melinta Therapeutics, Inc. | Orbactiv (Drug) | Food and Beverage | In-kind items and services | $105.18 | General |
| Category: ANTIBIOTICS | ||||||
| 02/13/2019 | PORTOLA PHARMACEUTICALS, INC. | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $130.81 | General |
| Category: HEMATOLOGY/NEUROLOGY | ||||||
| 01/10/2019 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $43.13 | General |
| Category: GIAPREZA | ||||||
| 11/29/2018 | Medtronic Vascular, Inc. | Reveal LINQ (Device) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 07/12/2018 | Melinta Therapeutics, Inc. | Baxdela (Drug), Vabomere, Orbactiv | Food and Beverage | Cash or cash equivalent | $92.63 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 03/08/2018 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $87.77 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/11/2017 | Valeant Pharmaceuticals North America LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $99.39 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/16/2017 | Valeant Pharmaceuticals North America LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/13/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $58.49 | General |
| Category: Cardiovascular | ||||||
| 05/10/2017 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $63.25 | General |
| Category: Hyperkalemia | ||||||
| 04/12/2017 | The Medicines Company | MINOCIN IV (Drug), ORBACTIV | Food and Beverage | In-kind items and services | $93.74 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/08/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $98.05 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 175 | 176 | $68,581 | $20,314 |
| 2022 | 5 | 305 | 307 | $94,821 | $32,595 |
| 2021 | 5 | 384 | 393 | $335,406 | $38,368 |
| 2020 | 5 | 710 | 742 | $862,552 | $88,405 |
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 78 | 79 | $35,313 | $10,606 | 30.0% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 59 | 59 | $18,172 | $5,057 | 27.8% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 23 | 23 | $12,351 | $3,864 | 31.3% |
| 99283 | Emergency department visit with low level of medical decision making | Facility | 2023 | 15 | 15 | $2,745 | $786.37 | 28.6% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 101 | 101 | $41,457 | $14,680 | 35.4% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 99 | 100 | $27,576 | $9,465 | 34.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 27 | 27 | $14,499 | $4,935 | 34.0% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 60 | 61 | $9,531 | $2,997 | 31.4% |
| 99282 | Emergency department visit for problem of mild to moderate severity | Facility | 2022 | 18 | 18 | $1,758 | $518.18 | 29.5% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 149 | 150 | $192,231 | $22,794 | 11.9% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 91 | 94 | $81,831 | $8,405 | 10.3% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 22 | 22 | $30,492 | $4,182 | 13.7% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 48 | 49 | $24,690 | $2,536 | 10.3% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 74 | 78 | $6,162 | $450.92 | 7.3% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 373 | 385 | $550,967 | $56,836 | 10.3% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 195 | 208 | $202,513 | $19,976 | 9.9% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 41 | 41 | $75,493 | $8,169 | 10.8% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 54 | 60 | $30,433 | $3,112 | 10.2% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 47 | 48 | $3,146 | $312.08 | 9.9% |
About Dr. Brandi Hyatt, D.O
Dr. Brandi Hyatt, D.O is a Emergency Medicine healthcare provider based in Oklahoma City, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/13/2014. The National Provider Identifier (NPI) number assigned to this provider is 1710398714.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brandi Hyatt, D.O has received a total of $1,337 in payments from pharmaceutical and medical device companies, with $177.25 received in 2023. These payments were reported across 17 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,337).
As a Medicare-enrolled provider, Hyatt has provided services to 1,574 Medicare beneficiaries, totaling 1,618 services with total Medicare billing of $179,682. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Practice Information
- Specialty Emergency Medicine
- Other Specialties Student in an Organized Health Care Education/Training Program, Emergency Medicine
- Location Oklahoma City, OK
- Active Since 05/13/2014
- Last Updated 09/03/2019
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1710398714
Products in Payments
- FLOWTRIEVER CATHETER, S (Device) $361.30
- ELIQUIS (Drug) $156.54
- ANDEXXA (Biological) $149.59
- XIFAXAN (Drug) $114.02
- Orbactiv (Drug) $105.18
- MINOCIN IV (Drug) $93.74
- Baxdela (Drug) $92.63
- BRILINTA (Drug) $87.77
- Veltassa (Drug) $63.25
- GIAPREZA (Drug) $43.13
- XARELTO (Drug) $34.13
- DIFICID (Drug) $20.75
- Reveal LINQ (Device) $14.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Oklahoma City
Alexander Frank, M.d, M.D
Emergency Medicine — Payments: $3.1M
Mohammad Razaq, M.d, M.D
Emergency Medicine — Payments: $177,813
Jose Borrego Acosta, Md, MD
Emergency Medicine — Payments: $76,213
Lindsey Epperson
Emergency Medicine — Payments: $36,931
Dr. Tyson Quy, M.d, M.D
Emergency Medicine — Payments: $35,983
Michael Partin, M.d, M.D
Emergency Medicine — Payments: $10,117